Back to mobile site

Sangamo BioSciences (SGMO) Heading Into Meaningful Data Presentation, Wedbush Reiterates Neutral

June 24, 2019 8:51 AM EDT Send to a Friend
Wedbush analyst Liana Moussatos reiterated a Neutral rating and $11.00 price target on Sangamo BioSciences (NASDAQ: SGMO) ahead of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login